Ubiquitin-Fold Modifier-1 Participates in the Diabetic Inflammatory Response by Regulating NF-κB p65 Nuclear Translocation and the Ubiquitination and Degradation of IκBα

References

• BoyleJJ, WeissbergPL, BennettMR. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol. 2003;23(9):1553–1558. doi:10.1161/01.ATV.0000086961.44581.B712869351
   PubMed Web of Science ®Google Scholar
• AtteleAS, ZhouYP, XieJT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002;51(6):1851–1858. doi:10.2337/diabetes.51.6.185112031973
   PubMed Web of Science ®Google Scholar
• van der MeerIM, RuggenentiP, RemuzziG. The diabetic CKD patient–a major cardiovascular challenge. J Ren Care. 2010;36(Suppl 1):34–46. doi:10.1111/jorc.2010.36.issue-s1
   PubMedGoogle Scholar
• AhmedM, de WintherMPJ, Van den BosscheJ. Epigenetic mechanisms of macrophage activation in type 2 diabetes. Immunobiology. 2017;222(10):937–943. doi:10.1016/j.imbio.2016.08.01127613200
   PubMed Web of Science ®Google Scholar
• KraakmanMJ, MurphyAJ, Jandeleit-DahmK, KammounHL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol. 2014;5:470. doi:10.3389/fimmu.2014.0047025309549
   PubMed Web of Science ®Google Scholar
• SuganamiT, NishidaJ, OgawaY. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25(10):2062–2068. doi:10.1161/01.ATV.0000183883.72263.1316123319
   PubMed Web of Science ®Google Scholar
• EsserN, Legrand-PoelsS, PietteJ, ScheenAJ, PaquotN. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150. doi:10.1016/j.diabres.2014.04.00624798950
   PubMed Web of Science ®Google Scholar
• WynnTA, ChawlaA, PollardJW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445–455. doi:10.1038/nature1203423619691
   PubMed Web of Science ®Google Scholar
• MaiorinoMI, BellastellaG, GiuglianoD, EspositoK. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. 2018;41(11):1249–1258. doi:10.1007/s40618-018-0872-629549630
   PubMed Web of Science ®Google Scholar
• MorrisDL. Minireview: emerging concepts in islet macrophage biology in Type 2 diabetes. Mol Endocrinol. 2015;29(7):946–962. doi:10.1210/me.2014-139326001058
   PubMedGoogle Scholar
• LawrenceT. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a00165120457564
   PubMed Web of Science ®Google Scholar
• CajeeUF, HullR, NtwasaM. Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways. Int J Mol Sci. 2012;13(9):11804–11831. doi:10.3390/ijms13091180423109884
   PubMed Web of Science ®Google Scholar
• YooHM, ParkJH, JeonYJ, ChungCH. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer. Front Endocrinol (Lausanne). 2015;6:36. doi:10.3389/fendo.2015.0003625852645
   PubMed Web of Science ®Google Scholar
• HochstrasserM. Origin and function of ubiquitin-like proteins. Nature. 2009;458(7237):422–429. doi:10.1038/nature0795819325621
   PubMed Web of Science ®Google Scholar
• PangQ, XiongJ, HuXL, et al. UFM1 protects macrophages from oxLDL-induced foam cell formation through a liver x receptor alpha dependent pathway. J Atheroscler Thromb. 2015;22(11):1124–1140. doi:10.5551/jat.2882926040753
   PubMed Web of Science ®Google Scholar
• HuX, PangQ, ShenQ, et al. Ubiquitin-fold modifier 1 inhibits apoptosis by suppressing the endoplasmic reticulum stress response in Raw264.7 cells. Int J Mol Med. 2014;33(6):1539–1546. doi:10.3892/ijmm.2014.172824714921
   PubMed Web of Science ®Google Scholar
• DesterroJM, RodriguezMS, HayRT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 1998;2(2):233–239. doi:10.1016/S1097-2765(00)80133-19734360
   PubMed Web of Science ®Google Scholar
• GongP, CanaanA, WangB, et al. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 2010;21(2):316–326. doi:10.1681/ASN.200905047919959714
   PubMed Web of Science ®Google Scholar
• HanX, TaoYL, DengYP, et al. Metformin ameliorates insulitis in STZ-induced diabetic mice. PeerJ. 2017;5:e3155. doi:10.7717/peerj.315528439456
   PubMed Web of Science ®Google Scholar
• HuX, ZhangX, JinG, ShiZ, SunW, ChenF. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways. Fundam Clin Pharmacol. 2017;31(1):54–63. doi:10.1111/fcp.2017.31.issue-127521287
   PubMed Web of Science ®Google Scholar
• JiangC, TongYL, ZhangD, LiuLZ, WangJF. Sinomenine prevents the development of cardiomyopathy in diabetic rats by inhibiting inflammatory responses and blocking activation of NF-kappaB. Gen Physiol Biophys. 2017;36(1):65–74. doi:10.4149/gpb_201603327901470
   PubMed Web of Science ®Google Scholar
• BaeuerlePA, BaltimoreD. NF-kappa B: ten years after. Cell. 1996;87(1):13–20. doi:10.1016/S0092-8674(00)81318-58858144
   PubMed Web of Science ®Google Scholar
• ZandiE, KarinM. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol Cell Biol. 1999;19(7):4547–4551. doi:10.1128/MCB.19.7.454710373503
   PubMed Web of Science ®Google Scholar
• BhushanS, TchatalbachevS, LuY, et al. Differential activation of inflammatory pathways in testicular macrophages provides a rationale for their subdued inflammatory capacity. J Immunol. 2015;194(11):5455–5464. doi:10.4049/jimmunol.140113225917085
   PubMed Web of Science ®Google Scholar
• TakadaY, IchikawaH, BadmaevV, AggarwalBB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006;176(5):3127–3140. doi:10.4049/jimmunol.176.5.312716493072
   PubMed Web of Science ®Google Scholar
• CoryTJ, HeH, WinchesterLC, KumarS, FletcherCV. Alterations in P-glycoprotein expression and function between macrophage subsets. Pharm Res. 2016;33(11):2713–2721. doi:10.1007/s11095-016-1998-x27431863
   PubMed Web of Science ®Google Scholar
• Abd EllahNH, TaylorL, AyresN, et al. NF-kappaB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Cancer Gene Ther. 2016;23(5):149–155. doi:10.1038/cgt.2016.1727125866
   PubMed Web of Science ®Google Scholar
• HuangW, XuL, ZhouX, et al. High glucose induces activation of NF-kappaB inflammatory signaling through IkappaBalpha sumoylation in rat mesangial cells. Biochem Biophys Res Commun. 2013;438(3):568–574. doi:10.1016/j.bbrc.2013.07.06523911785
   PubMed Web of Science ®Google Scholar
• FellmannL, NascimentoAR, TibiricaE, BousquetP. Murine models for pharmacological studies of the metabolic syndrome. Pharmacol Ther. 2013;137(3):331–340. doi:10.1016/j.pharmthera.2012.11.00423178510
   PubMed Web of Science ®Google Scholar
• IslamMS. Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res. 2013;2013:149452. doi:10.1155/2013/14945223984428
   PubMed Web of Science ®Google Scholar
• BetzB, ConwayBR. Recent advances in animal models of diabetic nephropathy. Nephron Exp Nephrol. 2014;126(4):191–195. doi:10.1159/00036330025034792
   PubMedGoogle Scholar
• ChowFY, Nikolic-PatersonDJ, OzolsE, AtkinsRC, TeschGH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol. 2005;16(6):1711–1722. doi:10.1681/ASN.200407061215857924
   PubMed Web of Science ®Google Scholar
• ChowFY, Nikolic-PatersonDJ, MaFY, OzolsE, RollinsBJ, TeschGH. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia. 2007;50(2):471–480. doi:10.1007/s00125-006-0497-817160673
   PubMed Web of Science ®Google Scholar
• HirotaH, YoshidaK, KishimotoT, TagaT. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995;92(11):4862–4866. doi:10.1073/pnas.92.11.48627539136
   PubMed Web of Science ®Google Scholar